Minot Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Minot Wealth Management's PFE Position: Q2 2022 in Review
Minot Wealth Management reduced its Pfizer (PFE) stake by 1.2% in Q2 2022, selling an estimated $35.6K and leaving 55,554 shares worth $2.91M. The position accounts for 0.75% of the portfolio, ranked #41.
Minot Wealth Management first reported a position in PFE in Q4 2019 and has held it in 11 quarters since. The position peaked at $3.37M in Q4 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.
- Minot Wealth Management held 55,554 shares of Pfizer worth $2.91M as of Q2 2022.
- Minot Wealth Management sold 699 Pfizer shares in Q2 2022, an estimated $35.6K.
- Pfizer made up 0.75% of Minot Wealth Management's portfolio in Q2 2022, its #41 holding.
- Minot Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 11 quarters since.
- Minot Wealth Management's Pfizer position peaked at $3.37M in Q4 2021.
- 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.
Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.